|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wöhrer SS, Raderer M and Hejna M:
Palliative chemotherapy for advanced gastric cancer. Ann Oncol.
15:1585–1595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spugnini EP, Buglioni S, Carocci F,
Francesco M, Vincenzi B, Fanciulli M and Fais S: High dose
lansoprazole combined with metronomic chemotherapy: A phase I/II
study in companion animals with spontaneously occurring tumors. J
Transl Med. 12:2252014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Holm E, Hagmüller E, Staedt U,
Schlickeiser G, Günther HJ, Leweling H, Tokus M and Kollmar HB:
Substrate balances across colonic carcinomas in humans. Cancer Res.
55:1373–1378. 1995.PubMed/NCBI
|
|
7
|
Vaupel P, Kallinowski F and Okunieff P:
Blood flow, oxygen and nutrient supply, and metabolic
microenvironment of human tumors: A review. Cancer Res.
49:6449–6465. 1989.PubMed/NCBI
|
|
8
|
Stubbs M, McSheehy PM and Griffiths JR:
Causes and consequences of acidic pH in tumors: A magnetic
resonance study. Adv Enzyme Regul. 39:13–30. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stubbs M, Rodrigues L, Howe FA, Wang J,
Jeong KS, Veech RL and Griffiths JR: Metabolic consequences of a
reversed pH gradient in rat tumors. Cancer Res. 54:4011–4016.
1994.PubMed/NCBI
|
|
10
|
Fais S: Proton pump inhibitor-induced
tumour cell death by inhibition of a detoxification mechanism. J
Intern Med. 267:515–525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sachs G, Shin JM and Howden CW: Review
article: The clinical pharmacology of proton pump inhibitors.
Aliment Pharmacol Ther. 23:(Suppl 2). 2–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gu M, Zhang Y, Zhou X, Ma H, Yao H and Ji
F: Rabeprazole exhibits antiproliferative effects on human gastric
cancer cell lines. Oncol Lett. 8:1739–1744. 2014.PubMed/NCBI
|
|
13
|
Zhang B, Yang Y, Shi X, Liao W, Chen M,
Cheng AS, Yan H, Fang C, Zhang S, Xu G, et al: Proton pump
inhibitor pantoprazole abrogates adriamycin-resistant gastric
cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin
signaling and epithelial-mesenchymal transition. Cancer Lett 356 (2
Pt B). 704–712. 2015. View Article : Google Scholar
|
|
14
|
Bitarte N, Bandres E, Boni V, Zarate R,
Rodriguez J, Gonzalez-Huarriz M, Lopez I, Sola J Javier, Alonso MM,
Fortes P, et al: MicroRNA-451 is involved in the self-renewal,
tumorigenicity, and chemoresistance of colorectal cancer stem
cells. Stem Cells. 29:1661–1671. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Levina V, Marrangoni A, Wang T, Parikh S,
Su Y, Herberman R, Lokshin A and Gorelik E: Elimination of human
lung cancer stem cells through targeting of the stem cell
factor-c-kit autocrine signaling loop. Cancer Res. 70:338–346.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Van den Broeck A, Vankelecom H, Van Delm
W, Gremeaux L, Wouters J, Allemeersch J, Govaere O, Roskams T and
Topal B: Human pancreatic cancer contains a side population
expressing cancer stem cell-associated and prognostic genes. PLoS
One. 8:e739682013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamashita T, Honda M, Nakamoto Y, Baba M,
Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, et al:
Discrete nature of EpCAM+ and CD90+ cancer
stem cells in human hepatocellular carcinoma. Hepatology.
57:1484–1497. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beck B, Driessens G, Goossens S, Youssef
KK, Kuchnio A, Caauwe A, Sotiropoulou PA, Loges S, Lapouge G, Candi
A, et al: A vascular niche and a VEGF-Nrp1 loop regulate the
initiation and stemness of skin tumours. Nature. 478:399–403. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bu P, Chen KY, Chen JH, Wang L, Walters J,
Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A
microRNA miR-34a-regulated bimodal switch targets Notch in colon
cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chaffer CL, Marjanovic ND, Lee T, Bell G,
Kleer CG, Reinhardt F, D'Alessio AC, Young RA and Weinberg RA:
Poised chromatin at the ZEB1 promoter enables breast cancer cell
plasticity and enhances tumorigenicity. Cell. 154:61–74. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Scaffidi P and Misteli T: In vitro
generation of human cells with cancer stem cell properties. Nat
Cell Biol. 13:1051–1061. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fagoonee S, Li H, Zhang H, Altruda F and
Pellicano R: Gastric cancer as a stem-cell disease: Data and
hypotheses. Panminerva Med. 56:289–300. 2014.PubMed/NCBI
|
|
24
|
Gao G, Sun Z, Wenyong L, Dongxia Y, Zhao R
and Zhang X: A preliminary study of side population cells in human
gastric cancer cell line HGC-27. Ann Transplant. 20:147–153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu ZY, Tang JN, Xie HX, Du YA, Huang L, Yu
PF and Cheng XD: 5-Fluorouracil chemotherapy of gastric cancer
generates residual cells with properties of cancer stem cells. Int
J Biol Sci. 11:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Z, Guo L, Liu D, Sun L, Chen H, Deng
Q, Liu Y, Yu M, Ma Y, Guo N, et al: Acquisition of resistance to
trastuzumab in gastric cancer cells is associated with activation
of IL-6/STAT3/Jagged-1/Notch positive feedback loop. Oncotarget.
6:5072–5087. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arocho A, Chen B, Ladanyi M and Pan Q:
Validation of the 2-DeltaDeltaCt calculation as an alternate method
of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho
SW, Kim HC and Hahm KB: Selective induction of apoptosis with
proton pump inhibitor in gastric cancer cells. Clin Cancer Res.
10:8687–8696. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lobo NA, Shimono Y, Qian D and Clarke MF:
The biology of cancer stem cells. Annu Rev Cell Dev Biol.
23:675–699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang S, Chen M, Ding X, Zhang X and Zou
X: Proton pump inhibitor selectively suppresses proliferation and
restores the chemosensitivity of gastric cancer cells by inhibiting
STAT3 signaling pathway. Int Immunopharmacol. 17:585–592. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lichner Z, Saleh C, Subramaniam V,
Seivwright A, Prud'homme GJ and Yousef GM: miR-17 inhibition
enhances the formation of kidney cancer spheres with stem
cell/tumor initiating cell properties. Oncotarget. 6:5567–5581.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prud'homme GJ: Cancer stem cells and novel
targets for antitumor strategies. Curr Pharm Des. 18:2838–2849.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yeo M, Kim DK, Park HJ, Cho SW, Cheong JY
and Lee KJ: Blockage of intracellular proton extrusion with proton
extrusions with proton pump inhibitor induces apoptosis in gastric
cancer. Cancer Sci. 99:1852008.
|
